Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma

Figure 7

Submap analysis predicted the response to anti-PD-1 and anti-CTLA4 therapy for H-TIIC and L-TIIC subtypes in (a) TARGET cohort and (b) GSE21257 cohort. R represents immunotherapy responders. Bonferroni corrected value < 0.05 was considered statistically significant.

(a)

(b)